Ozempic approved for type 2 diabetes
(HealthDay)—Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.
Dec 6, 2017
0
4
(HealthDay)—Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.
Dec 6, 2017
0
4
If you feel chest pain, get to a doctor fast. Nothing you're about to read below should dissuade you from that common-sense advice.
Jan 8, 2019
0
1
A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January ...
Feb 4, 2015
0
15
Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they're getting the medication, the U.S. Food and Drug Administration warned Tuesday.
May 31, 2023
0
56
(Phys.org) -- Scientists at the University of Reading have made a groundbreaking discovery into the way blood clots are formed, potentially leading to the development of new drugs to treat one of the world's biggest killer ...
Apr 27, 2012
0
0
A quarter of the participants in a long-term study of older people experiencing homelessness in Oakland died within a few years of being enrolled, UC San Francisco researchers found.
Aug 29, 2022
0
63
(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online ...
Jul 23, 2013
0
0
If heart attacks blared a warning signal, patients would have a better chance of avoiding them. That's the idea behind a new imaging technique developed by a Spartan-led team of researchers.
Aug 9, 2021
0
278
Patients who have suffered a heart attack should immediately be offered a combination of cholesterol lowering drugs with statins and ezetimibe, according to research published in the Journal of the American Heart Association.
Sep 6, 2023
0
8
UC Davis scientists have developed a novel cardiovascular agent which, unlike currently available drugs for heart disease, does not target high blood cholesterol or high blood pressure. The experimental agent inhibits C-reactive ...
Jul 25, 2013
0
0